| GO processes |
| GO:0006355: regulation of transcription, DNA-dependent |
1.44E-99 |
584 |
| GO:0007165: signal transduction |
3.90E-65 |
415 |
| GO:0045944: positive regulation of transcription from RNA polymerase II promoter |
1.73E-60 |
255 |
| GO:0007275: multicellular organismal development |
2.49E-57 |
344 |
| GO:0045893: positive regulation of transcription, DNA-dependent |
4.03E-53 |
213 |
| GO:0045892: negative regulation of transcription, DNA-dependent |
7.61E-50 |
189 |
| GO:0000122: negative regulation of transcription from RNA polymerase II promoter |
2.83E-46 |
188 |
| GO:0007411: axon guidance |
3.19E-46 |
156 |
| GO:0007264: small GTPase mediated signal transduction |
1.86E-41 |
151 |
| GO:0007399: nervous system development |
1.95E-41 |
179 |
| KEGG pathways |
| Kegg:05200: Pathways in cancer |
6.81E-32 |
140 |
| Kegg:04510: Focal adhesion |
7.54E-30 |
100 |
| Kegg:04010: MAPK signaling pathway |
6.53E-30 |
119 |
| Kegg:04360: Axon guidance |
9.56E-30 |
77 |
| Kegg:04810: Regulation of actin cytoskeleton |
7.85E-27 |
99 |
| Kegg:04722: Neurotrophin signaling pathway |
5.66E-24 |
69 |
| Kegg:04144: Endocytosis |
3.31E-23 |
89 |
| Kegg:04520: Adherens junction |
5.84E-22 |
48 |
| Kegg:04141: Protein processing in endoplasmic reticulum |
1.07E-19 |
74 |
| Kegg:04910: Insulin signaling pathway |
9.19E-19 |
65 |
| Panther Pathways |
| Panther:P00018: EGF receptor signaling pathway |
3.82E-21 |
63 |
| Panther:P00034: Integrin signalling pathway |
1.99E-20 |
75 |
| Panther:P00047: PDGF signaling pathway |
2.15E-17 |
62 |
| Panther:P00057: Wnt signaling pathway |
2.92E-17 |
102 |
| Panther:P00021: FGF signaling pathway |
1.16E-16 |
55 |
| Panther:P00005: Angiogenesis |
3.34E-16 |
67 |
| Panther:P04393: Ras Pathway |
3.89E-14 |
39 |
| Panther:P00031: Inflammation mediated by chemokine and cytokine signaling pathway |
5.79E-13 |
73 |
| Panther:P00052: TGF-beta signaling pathway |
5.03E-12 |
43 |
| Panther:P00029: Huntington disease |
1.34E-11 |
52 |
